First malaria vaccine rolled out in Africa—despite limited efficacy and nagging safety concerns By Jop de VriezeNov. 26, 2019
Podcast: Do scientists make great contributions after 30? We chat with experts about some common scientific myths By Sarah Crespi, Jop de VriezeSep. 20, 2018
Meta-analyses were supposed to end scientific debates. Often, they only cause more controversy By Jop de VriezeSep. 18, 2018
Open-access journal editors resign after alleged pressure to publish mediocre papers By Jop de VriezeSep. 4, 2018
Trials of impotence drug to help poorly growing fetuses are halted after infant deaths By Jop de VriezeJul. 25, 2018
Scientists beware: The price is high, the payoff uncertain at glossy publications aimed at Europe’s decision-makers By Jop de VriezeMar. 14, 2018
This new index ranks companies’ efforts in the fight against antimicrobial resistance By Jop de VriezeJan. 23, 2018
Nearly 100 scientists spent 2 months on Google Docs to redefine the p-value. Here’s what they came up with By Jop de VriezeJan. 18, 2018
‘Replication grants’ will allow researchers to repeat nine influential studies that still raise questions By Jop de VriezeJul. 11, 2017
With this new system, scientists never have to write a grant application again By Jop de VriezeApr. 13, 2017
